V

Vital Farms

Ethically produced, pasture-raised eggs and dairy

Overview

Vital Farms produces ethically raised eggs and dairy by partnering with about 200 family farms. Producers give hens pasture access of at least 108 square feet, with fresh air and sun year-round. The company sells pasture-raised products to consumers who care about animal welfare and sustainability, often at a premium price. Its model centers on farm partnerships and maintaining high ethical standards, ensuring transparency and environmental stewardship. Customers can engage with the brand through experiences like the Pasture Passport, which lets them virtually visit the farms where eggs are laid and participate in birdwatching. Overall, Vital Farms aims to bring ethically produced food to tables by supporting small, welfare-focused farms and offering transparent, premium products.

Work here?Claim your company

About Vital Farms

Simplify's Rating
Why Vital Farms is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Food & AgricultureSocial ImpactConsumer Goods

Company Size

501-1,000

Company Stage

IPO

Headquarters

Austin, TX

Founded

2007

Get referred to Vital Farms

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • August 4, 2026 financing added $185 million liquidity through Silver Point and JPMorgan facilities.
  • April 2026 butter wind-down and lower 2026 capex refocus cash on core eggs.
  • Management targets $2 billion net sales by 2030, backed by Seymour capacity additions.

What critics are saying

  • The May 8, 2025-February 26, 2026 ERP class action attacks disclosure credibility and governance.
  • August 3, 2026 covenant waivers and stock-buyback cancellation signal stressed operations after missed guidance.
  • Retailers can replace Vital Farms shelf space quickly; repeated disruptions destroy premium economics.

What makes Vital Farms unique

  • Vital Farms leads U.S. pasture-raised eggs with 600 family farms and premium pricing.
  • Its 108-square-foot pasture standard and humane-brand trust create retailer and consumer loyalty.
  • The 2026 leadership transition kept Russell Diez-Canseco in control with Matt O'Hayer advisory.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$297.3M

Meets

Industry Average

Funded Over

13 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Parental Leave
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Employee Discounts
  • Professional Development Budget
  • Remote Work Options
  • Flexible Work Hours

Stock Price

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

2%
eFeedLink
Nov 7th, 2026
Vital Farms swings to Q3 loss and cuts 2026 revenue outlook to US$730 million as egg oversupply hits margins.

Vital Farms swings to Q3 loss and cuts 2026 revenue outlook to US$730 million as egg oversupply hits margins. eFeedLink Newsdesk | 7 Nov 2026 The US pasture-raised egg producer's gross margin fell to 23.1% from 37.7% as surplus eggs were sold into lower-priced breaker and wholesale channels. **US egg company Vital Farms posted a net loss of US$6.5 million in the third quarter of 2026, against net income of US$16.4 million a year earlier, as net revenue fell 8.4% to US$182.2 million. The company cut its full-year revenue outlook to around US$730 million from US$775-800 million.** Price and mix accounted for US$14.3 million of the revenue decline in the 13 weeks to 27 September 2026, with a volume-driven decline of US$2.2 million excluding breaker and wholesale sales. Revenue rose 9.7% from the second quarter. Gross margin fell to 23.1% from 37.7%, reflecting higher input and production costs and an unfavourable sales mix. The company said an oversupply of egg inventory led to increased sales to breaker and wholesale channels at lower prices, reducing gross profit by US$7.9 million. Adjusted EBITDA fell to US$1.5 million from US$27.4 million. For the first nine months, net revenue was US$535.3 million compared with US$545.9 million, and the company swung to a net loss of US$39.0 million from net income of US$50.0 million. Vital Farms now expects a full-year adjusted EBITDA loss of around US$15 million, compared with its previous outlook of breakeven to US$10 million, and has withdrawn its fiscal 2030 long-term targets. Capital expenditure guidance of US$70-75 million was reaffirmed. The company said the revised outlook reflects later-than-anticipated timing of some new distribution placements and assumes no seasonal uplift in demand or conventional egg pricing. Russell Diez-Canseco, executive chairperson, president and chief executive officer, said the quarter came "as the egg category has normalized following several years of disruption from avian influenza." He added: "We achieved the distribution gains we expected, although some of that distribution came on shelf later than planned." Chief Financial Officer Thilo Wrede said: "We continue to expect sequential improvement in Q4 compared with Q3," citing "lower anticipated breaker and supply-management costs." The company sources from a network of more than 600 small farms and held cash of US$84.0 million against debt of US$117.6 million at quarter end. - Vital Farms

Transcript Daily
Nov 6th, 2026
Vital Farms Q3 earnings call highlights.

Vital Farms Q3 earnings call highlights. Vital Farms (NASDAQ:VITL) reported third-quarter results that improved sequentially from the prior quarter but declined from a year earlier, as the specialty egg producer continued to adjust supply and lowered its full-year outlook amid softer-than-expected seasonal demand. The company reported third-quarter net revenue of $182.2 million, up 10% from the second quarter but down $16.8 million, or 8.4%, from the year-ago period. Chief Financial Officer Thilo Wrede said the year-over-year decline primarily reflected $14.3 million of lower price and mix and $2.2 million of lower volume excluding breaker and wholesale channels. Gross profit was $42.1 million, representing a gross margin of 23.1%, an improvement of more than 16 percentage points from the second quarter. Adjusted EBITDA was $1.5 million, compared with a $26.6 million adjusted EBITDA loss in the prior quarter. Supply actions support sequential margin recovery. Executive Chairperson, President and CEO Russell Diez-Canseco said the company's recovery from the second quarter was supported primarily by changes to farmer contracts that gave Vital Farms more control over supply. The amendments have been implemented, and the volume sent to breaker and wholesale channels declined 59% from the second quarter. Diez-Canseco described the reduction in those channels as the largest contributor to the company's margin recovery. Wrede said breaker volume represented about an $8 million impact to EBITDA in the third quarter, compared with a $21 million impact in the second quarter. He said the company expects to make further progress managing excess supply, although some excess volume is still expected to be sold through breaker and wholesale channels in the fourth quarter. Vital Farms also said it completed efficiency actions announced in May and July that are expected to reduce its annualized SG&A run rate by approximately $6 million to $7 million. Third-quarter SG&A expense was $38.1 million, down $6.3 million, or 14%, from the prior-year period. Shipping and distribution expense increased to $11.7 million from $9.2 million a year earlier, driven primarily by higher fuel rates and unfavorable line-haul rates. Company lowers full-year sales and EBITDA outlook. Vital Farms reduced its full-year net-sales outlook to about $730 million, from a prior range of $775 million to $800 million. The company also lowered its adjusted EBITDA outlook to about a $15 million loss, compared with prior guidance for adjusted EBITDA ranging from breakeven to a $10 million gain. Management cited three factors behind the lower fourth-quarter expectations: * Demand has not shown the normal seasonal build into the holiday period, with retailers buying closer to immediate needs rather than building inventory ahead of Thanksgiving. * Some recently secured distribution reached store shelves several weeks later than expected, reducing the number of selling weeks in the quarter. * The company no longer assumes conventional egg prices will rise seasonally into the holidays, which would ordinarily narrow the price gap between Vital Farms products and conventional eggs. For the fourth quarter, Vital Farms expects shell egg distribution to remain above 175 total distribution points, or TDPs, in Circana MULO+ data. The company expects fourth-quarter unit velocity of approximately 25.9 equivalent units per store per week per item, compared with 25.3 in the third quarter. Dollar velocity is expected to decline to approximately $200 per store per week per item from roughly $205 in the third quarter, reflecting increased promotional activity and slower initial turns at newer distribution points. Vital Farms also expects to generate $3 million to $4 million in butter net sales during the fourth quarter as it sells its remaining bulk and finished-goods butter inventory. Wrede said butter is margin dilutive and that exiting the business by year-end could support margin improvement in 2027. Pricing view shifts toward private-label competition. Diez-Canseco said the company believes its performance this year has been affected largely by households that tried Vital Farms products when avian influenza compressed price differences across the egg aisle in 2024 and 2025, then returned to lower-priced private-label products as egg supply normalized. Store-brand egg prices have returned to approximately $2 per dozen, according to management, and Vital Farms said its price premium relative to other outdoor-access brands is now near where it stood in the third quarter of 2023, the last period management characterized as a fully supplied market. "Our pricing is actually not excessively high," Diez-Canseco said during the question-and-answer session. He said the company now believes that most of the lost volume came from light buyers returning to private-label offerings rather than customers switching to branded competitors. As a result, the company said its pricing approach is no longer centered on narrowing gaps with branded competitors. Instead, management said promotions will be used selectively to encourage product trial rather than broadly to drive short-term volume. Despite the softer comparison with 2025, Diez-Canseco said the company's third-quarter revenue was about 65% above third-quarter 2023 levels, while velocities were approximately unchanged despite nearly 60% more distribution points. Vital Farms ended the third quarter with a record 7.2% dollar share and 2.3% volume share of shell eggs in Circana MULO+ data. Capacity spending paused; long-term targets withdrawn. The company ended the quarter with $84 million in cash and $117.6 million of outstanding debt. Capital expenditures totaled $14.3 million in the third quarter and $51.7 million year to date. At its Vital Crossroads facility, Vital Farms has largely completed work needed to enclose the building and plans to pause construction after completing the frame, walls and roof. Full-year capital spending guidance remains $70 million to $75 million, down from the $140 million to $150 million projected in February. Diez-Canseco said the company's existing Egg Central Station facility is operating with high uptime and fill rates following the addition of a third production line. He said the facility has a run-rate capacity of roughly $1 billion in net revenue, though additional capacity would likely be needed before the company reaches that annualized level because of seasonality and distribution timing. Vital Farms also withdrew its 2030 financial targets, saying it intends to focus on near-term execution, margin expansion and profitability before revisiting longer-term targets. The company is additionally conducting a limited test of a free-range egg product, which management said could address a larger portion of the egg market, though it does not expect the pilot to materially affect 2027 results. About Vital Farms (NASDAQ:VITL). Vital Farms, Inc is a food company that produces and markets pasture-raised eggs and other ethically sourced food products. Its offerings include pasture-raised eggs, butter, hard-boiled eggs and ghee, sold under the Vital Farms brand. Founded in 2007, the company works with a network of family farms and focuses on animal welfare, outdoor access and supply-chain transparency. Vital Farms products are distributed primarily through grocery retailers and other food channels across the United States. Vital Farms is headquartered in Austin, Texas.

Yahoo Finance
Nov 3rd, 2026
Vital Farms posts $6.5M Q3 loss, missing Wall Street forecasts on $182.2M revenue

Vital Farms reported a third-quarter loss of $6.5 million, or 15 cents per share. Analysts surveyed by Zacks Investment Research had expected a loss of 13 cents per share. The Austin, Texas-based company posted revenue of $182.2 million, just short of the $182.3 million analysts forecast.

MarketBeat
Nov 3rd, 2026
Vital Farms Q3 earnings call highlights.

Vital Farms Q3 earnings call highlights. November 3, 2026 Key points. * Third-quarter results improved sequentially but declined year over year: Revenue was $182.2 million, down 8.4% from a year earlier, while gross margin recovered to 23.1% and adjusted EBITDA improved to a $1.5 million loss from a $26.6 million loss in Q2. * Supply-control measures supported the margin recovery. Volume sent to breaker and wholesale channels fell 59% from Q2, while cost-cutting actions are expected to reduce annualized SG&A by $6 million to $7 million. * Vital Farms lowered its full-year outlook to approximately $730 million in sales and a $15 million adjusted EBITDA loss, citing weaker seasonal demand, delayed distribution gains and less favorable conventional egg pricing. The company also paused major capacity spending and withdrew its 2030 financial targets. * Interested in Vital Farms? Here are five stocks we like better. Vital Farms NASDAQ: VITL reported third-quarter results that improved sequentially from the prior quarter but declined from a year earlier, as the specialty egg producer continued to adjust supply and lowered its full-year outlook amid softer-than-expected seasonal demand. The company reported third-quarter net revenue of $182.2 million, up 10% from the second quarter but down $16.8 million, or 8.4%, from the year-ago period. Chief Financial Officer Thilo Wrede said the year-over-year decline primarily reflected $14.3 million of lower price and mix and $2.2 million of lower volume excluding breaker and wholesale channels. Gross profit was $42.1 million, representing a gross margin of 23.1%, an improvement of more than 16 percentage points from the second quarter. Adjusted EBITDA was $1.5 million, compared with a $26.6 million adjusted EBITDA loss in the prior quarter. Supply actions support sequential margin recovery. Executive Chairperson, President and CEO Russell Diez-Canseco said the company's recovery from the second quarter was supported primarily by changes to farmer contracts that gave Vital Farms more control over supply. The amendments have been implemented, and the volume sent to breaker and wholesale channels declined 59% from the second quarter. Diez-Canseco described the reduction in those channels as the largest contributor to the company's margin recovery. Wrede said breaker volume represented about an $8 million impact to EBITDA in the third quarter, compared with a $21 million impact in the second quarter. He said the company expects to make further progress managing excess supply, although some excess volume is still expected to be sold through breaker and wholesale channels in the fourth quarter. Vital Farms also said it completed efficiency actions announced in May and July that are expected to reduce its annualized SG&A run rate by approximately $6 million to $7 million. Third-quarter SG&A expense was $38.1 million, down $6.3 million, or 14%, from the prior-year period. Discover more Dividend Screener Tool Track Stock Market Invest in Stocks Shipping and distribution expense increased to $11.7 million from $9.2 million a year earlier, driven primarily by higher fuel rates and unfavorable line-haul rates. Company lowers full-year sales and EBITDA outlook. Vital Farms reduced its full-year net-sales outlook to about $730 million, from a prior range of $775 million to $800 million. The company also lowered its adjusted EBITDA outlook to about a $15 million loss, compared with prior guidance for adjusted EBITDA ranging from breakeven to a $10 million gain. Management cited three factors behind the lower fourth-quarter expectations: * Demand has not shown the normal seasonal build into the holiday period, with retailers buying closer to immediate needs rather than building inventory ahead of Thanksgiving. * Some recently secured distribution reached store shelves several weeks later than expected, reducing the number of selling weeks in the quarter. * The company no longer assumes conventional egg prices will rise seasonally into the holidays, which would ordinarily narrow the price gap between Vital Farms products and conventional eggs. For the fourth quarter, Vital Farms expects shell egg distribution to remain above 175 total distribution points, or TDPs, in Circana MULO+ data. The company expects fourth-quarter unit velocity of approximately 25.9 equivalent units per store per week per item, compared with 25.3 in the third quarter. Dollar velocity is expected to decline to approximately $200 per store per week per item from roughly $205 in the third quarter, reflecting increased promotional activity and slower initial turns at newer distribution points. Vital Farms also expects to generate $3 million to $4 million in butter net sales during the fourth quarter as it sells its remaining bulk and finished-goods butter inventory. Wrede said butter is margin dilutive and that exiting the business by year-end could support margin improvement in 2027. Pricing view shifts toward private-label competition. Diez-Canseco said the company believes its performance this year has been affected largely by households that tried Vital Farms products when avian influenza compressed price differences across the egg aisle in 2024 and 2025, then returned to lower-priced private-label products as egg supply normalized. Store-brand egg prices have returned to approximately $2 per dozen, according to management, and Vital Farms said its price premium relative to other outdoor-access brands is now near where it stood in the third quarter of 2023, the last period management characterized as a fully supplied market. "Our pricing is actually not excessively high," Diez-Canseco said during the question-and-answer session. He said the company now believes that most of the lost volume came from light buyers returning to private-label offerings rather than customers switching to branded competitors. As a result, the company said its pricing approach is no longer centered on narrowing gaps with branded competitors. Instead, management said promotions will be used selectively to encourage product trial rather than broadly to drive short-term volume. Despite the softer comparison with 2025, Diez-Canseco said the company's third-quarter revenue was about 65% above third-quarter 2023 levels, while velocities were approximately unchanged despite nearly 60% more distribution points. Vital Farms ended the third quarter with a record 7.2% dollar share and 2.3% volume share of shell eggs in Circana MULO+ data. Capacity spending paused; long-term targets withdrawn. The company ended the quarter with $84 million in cash and $117.6 million of outstanding debt. Capital expenditures totaled $14.3 million in the third quarter and $51.7 million year to date. At its Vital Crossroads facility, Vital Farms has largely completed work needed to enclose the building and plans to pause construction after completing the frame, walls and roof. Full-year capital spending guidance remains $70 million to $75 million, down from the $140 million to $150 million projected in February. Diez-Canseco said the company's existing Egg Central Station facility is operating with high uptime and fill rates following the addition of a third production line. He said the facility has a run-rate capacity of roughly $1 billion in net revenue, though additional capacity would likely be needed before the company reaches that annualized level because of seasonality and distribution timing. Vital Farms also withdrew its 2030 financial targets, saying it intends to focus on near-term execution, margin expansion and profitability before revisiting longer-term targets. The company is additionally conducting a limited test of a free-range egg product, which management said could address a larger portion of the egg market, though it does not expect the pilot to materially affect 2027 results. About Vital Farms (NASDAQ:VITL). Vital Farms, Inc is a food company that produces and markets pasture-raised eggs and other ethically sourced food products. Its offerings include pasture-raised eggs, butter, hard-boiled eggs and ghee, sold under the Vital Farms brand. Founded in 2007, the company works with a network of family farms and focuses on animal welfare, outdoor access and supply-chain transparency. Vital Farms products are distributed primarily through grocery retailers and other food channels across the United States. Vital Farms is headquartered in Austin, Texas. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Vital Farms, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list. While Vital Farms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public. Continue following MarketBeat

FinancialContent
Nov 2nd, 2026
Vital Farms (VITL) reports earnings tomorrow: what to expect.

Vital Farms (VITL) reports earnings tomorrow: what to expect. November 01, 2026 at 22:20 PM EST i This article is third-party content and does not represent the views of this site. Tamar Securities, LLC make no guarantees regarding its accuracy or completeness. Egg and butter company Vital Farms (NASDAQ: VITL) will be reporting earnings this Tuesday before market open. Here's what investors should know. Vital Farms beat analysts' revenue expectations last quarter, reporting revenues of $166 million, down 10.1% year on year. It was a satisfactory quarter for the company, with full-year EBITDA guidance exceeding analysts' expectations but a significant miss of analysts' EBITDA estimates. This quarter, the market is expecting Vital Farms's revenue to decline 8.4% year on year, a reversal from the 37.2% increase it recorded in the same quarter last year. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Vital Farms has missed Wall Street's revenue estimates multiple times over the last two years. Looking at Vital Farms's peers in the consumer staples segment, some have already reported their Q3 results, giving Tamar Securities, LLC a hint as to what Tamar Securities, LLC can expect. Pilgrim's Pride's revenues decreased 2.2% year on year, missing analysts' expectations by 0.8%, and Cal-Maine reported a revenue decline of 41.5%, falling short of estimates by 3.9%. Pilgrim's Pride traded up 4.7% following the results while Cal-Maine was down 4%. There has been positive sentiment among investors in the consumer staples segment, with share prices up 6.3% on average over the last month. Vital Farms is down 6.2% during the same time and is heading into earnings with an average analyst price target of $12.22 (compared to the current share price of $8.68). ALSO WORTH WATCHING: Nvidia's Quiet Partner. Nvidia's chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all. Every AI server needs specialized infrastructure the chip companies don't make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE. Report this content If you believe this article contains misleading, harmful, or spam content, please let Tamar Securities, LLC know.

Recently Posted Jobs

Sign up to get curated job recommendations

Vital Farms is Hiring for 16 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs